Silvana Canevari - Concepedia

Author

Silvana Canevari

Fondazione IRCCS Istituto Nazionale dei Tumori ORCID

Also Known As

Canevari Silvana, Canevari, Silvana, S Canevari, S. Canevari, SILVANA CANEVARI, Silvana CANEVARI, Silvana Canevari

411

Publications

11.3K

Citations

H-Index

119

Concepts

All Affiliations

Fondazione IRCCS Istituto Nazionale dei Tumori University of Milan Alleanza Contro il Cancro Istituto Superiore di Sanità University of L'Aquila

About

Silvana Canevari is an author at Fondazione IRCCS Istituto Nazionale dei Tumori specializing in medicine, tumor biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	38	79	4.4K
2	Health Sciences	6	6	335
3	Natural Sciences	6	6	466
4	Engineering	4	4	144
5	Allergy	2	2	35

Silvana Canevari

167

Publications

9.6K

Citations

H-Index

Page 1

	Year	Citations
A Phase I Study on Adoptive Immunotherapy Using Gene-Modified T Cells for Ovarian Cancer Michael H. Kershaw, Jennifer A. Westwood, Linda L. Parker, Clinical Cancer Research	2006	1.2K
Alterations of Choline Phospholipid Metabolism in Ovarian Tumor Progression Egidio Iorio, Delia Mezzanzanica, Paola Alberti, Cancer Research Tumor BiologyOxysterolChemoprevention StrategyBiochemistryAbnormal Phosphatidylcholine Metabolism	2005	322
Characterization of human ovarian carcinoma‐associated antigens defined by novel monoclonal antibodies with tumor‐restricted specificity Silvia Miotti, Silvana Canevari, Sylvie Ménard, International Journal of Cancer	1987	317
Generation of monoclonal antibodies reacting with normal and cancer cells of human breast. Sylvie Ménard, Elda Tagliabue, Silvana Canevari, PubMed Breast OncologyImmunologyPathologyImmunotherapyTumor Biology	1983	230
Activation of Phosphatidylcholine Cycle Enzymes in Human Epithelial Ovarian Cancer Cells Egidio Iorio, Alessandro Ricci, Marina Bagnoli, Cancer Research Chemoprevention StrategyCancer BiologyTumor BiologyOvarian CancerSignaling Pathway	2010	222
Characterization of a glycosphingolipid antigen defined by the monoclonal antibody MBr1 expressed in normal and neoplastic epithelial cells of human mammary gland. Eric G. Bremer, Steven B. Levery, Sandro Sonnino, Journal of Biological Chemistry	1984	205
Regression of Advanced Ovarian Carcinoma by Intraperitoneal Treatment With Autologous TLymphocytes Retargeted by a Bispecific Monoclonal Antibody Silvana Canevari, Gerrit Stoter, Flavio Arienti, JNCI Journal of the National Cancer Institute	1995	191
Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro Vincenza Dolo, Sandra D’Ascenzo, Stefania Violini, Clinical & Experimental Metastasis	1999	157
Selective localization of matrix metalloproteinase 9, beta1 integrins, and human lymphocyte antigen class I molecules on membrane vesicles shed by 8701-BC breast carcinoma cells. Vincenza Dolo, A Ginestra, Donata Cassarà, PubMed Matrix Metalloproteinase 9Immunocytochemical TechniqueShed VesiclesImmunologyExtracellular Microvesicles	1998	142
Human Cutaneous Melanomas Lacking MITF and Melanocyte Differentiation Antigens Express a Functional Axl Receptor Kinase Marialuisa Sensi, Mara Catani, Giancarlo Castellano, Journal of Investigative Dermatology Signal TransductionCutaneous BiologyMelanomaImmunologyDermatology	2011	141

Page 1